Raymond James & Associates’s Marker Therapeutics MRKR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,400	Closed	-$25K	–	3874
2022 Q4	$25K	Hold	9,400	–	–	﹤0.01%	3703
2022 Q3	$35K	Buy	+9,400	New	+$35K	﹤0.01%	3688